{"id":4710,"date":"2019-07-30T22:33:31","date_gmt":"2019-07-31T02:33:31","guid":{"rendered":"https:\/\/kabs.com\/?page_id=4710"},"modified":"2024-12-12T19:43:50","modified_gmt":"2024-12-13T00:43:50","slug":"news-video","status":"publish","type":"page","link":"https:\/\/kabs.com\/en\/news-video\/","title":{"rendered":"News\/video"},"content":{"rendered":"

[vc_row][vc_column][vc_empty_space height=”122px”][\/vc_column][\/vc_row][vc_row][vc_column][vc_single_image image=”8752″ img_size=”full” css_animation=”fadeIn”][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css_animation=”fadeIn”]<\/p>\n

March 16 \/ 2021<\/strong><\/h6>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css_animation=”fadeIn”]<\/p>\n

KABS LABORATORIES ANNOUNCE A SIGNIFICANT SUPPORT FROM THE STRATEGIC INNOVATION FUND<\/strong><\/h4>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css_animation=”fadeIn”]<\/p>\n

We are pleased to announce a significant support from the Strategic Innovation Fund which allows KABS to accelerate its activities in the field of bioprocesses and the development of biological drugs at St-Hubert and Val-des-Sources.\u00a0We would like to thank the Government of Canada, the Municipality of Val-des-Sources, and the Sherbrooke Office of Investissement Quebec for their continuous and diligent attention to our projects.<\/span><\/strong><\/span><\/h5>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css_animation=”fadeIn”]<\/p>\n

\u201cCanada\u2019s biomanufacturing sector is rich in knowledge and expertise. By investing in domestic biomanufacturing facilities and equipment, such as KABS Laboratories, Novocol and Immune Biosolutions, we are investing in made-in-Canada solutions to fight COVID-19 while retaining and developing the expertise necessary to help us secure vaccine and therapy supply chains here at home. Our government is committed to rebuilding Canada\u2019s biomanufacturing sector, focusing on both short-term strategic solutions and a long-term vision.\u201d<\/span><\/h5>\n
\u2013 The Honourable Fran\u00e7ois-Philippe Champagne, Minister of Innovation, Science and Industry<\/span><\/h5>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=”44px”][\/vc_column][\/vc_row][vc_row][vc_column]\r\n VIEW FULL TEXT<\/span>\r\n <\/a>[\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=”44px”][\/vc_column][\/vc_row][vc_row][vc_column]

\r\n\t
<\/div>\r\n<\/div>\r\n[\/vc_column][\/vc_row][vc_row css=”.vc_custom_1566346518523{margin-top: 66px !important;}”][vc_column][vc_separator border_width=”2″ css_animation=”fadeInUp”][\/vc_column][\/vc_row][vc_row][vc_column][vc_single_image image=”5275″ img_size=”full” css_animation=”fadeIn”][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css_animation=”fadeIn”]<\/p>\n
May 13 \/ 2020<\/strong><\/h6>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css_animation=”fadeIn”]<\/p>\n

Exvastat receives prestigious Innovative Medicines Initiative\u00a0grant to fund clinical study\u00a0of imatinib in the treatment of COVID-19-associated ARDS. <\/strong><\/h4>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css_animation=”fadeIn”]<\/p>\n

Under the award, Exvastat will collaborate with Vrije Universitat, Amsterdam Medical Center, KABS (Canada) and Simbec-Orion to produce a reformulated version of the drug and test it in critically ill COVID-19 patients.<\/h5>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=”22px”][\/vc_column][\/vc_row][vc_row][vc_column][vc_empty_space height=”22px”][\/vc_column][\/vc_row][vc_row][vc_column]\r\n VIEW FULL TEXT<\/span>\r\n <\/a>[\/vc_column][\/vc_row][vc_row css=”.vc_custom_1566346518523{margin-top: 66px !important;}”][vc_column][vc_separator border_width=”2″ css_animation=”fadeInUp”][\/vc_column][\/vc_row][vc_row css=”.vc_custom_1566346638452{padding-top: 80px !important;padding-bottom: 80px !important;}”][vc_column css_animation=”fadeIn”]

\r\n
\r\n\t\t

\r\n\t\tOne product : Commitment <\/h4>\r\n\t\t
Our history in images.<\/div>\r\n\t
\r\n\t\t\r\n <\/span>\r\n <\/a> <\/div>\r\n<\/div> \r\n\r\n
\r\n\t\t
\r\n
\r\n\t\t\"\" <\/div>\r\n \r\n\t\t\t\r\n\t\t\t\t\r\n\t\t\t\t\t\r\n\t\t\t\t\t\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/span>\r\n <\/a>\r\n<\/div> <\/div> \r\n<\/div> \r\n\r\n\r\n[\/vc_column][\/vc_row][vc_row][vc_column][vc_text_separator title=”By people, for people.” title_align=”separator_align_right” border_width=”2″ css_animation=”slideInLeft”][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_empty_space height=”122px”][\/vc_column][\/vc_row][vc_row][vc_column][vc_single_image image=”8752″ img_size=”full” css_animation=”fadeIn”][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css_animation=”fadeIn”] March 16 \/ 2021 [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css_animation=”fadeIn”] KABS LABORATORIES ANNOUNCE A SIGNIFICANT SUPPORT FROM THE STRATEGIC INNOVATION FUND [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css_animation=”fadeIn”] We are pleased to announce a significant support from the Strategic Innovation Fund which allows […]<\/p>\n","protected":false},"author":1,"featured_media":8712,"parent":0,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-4710","page","type-page","status-publish","has-post-thumbnail","hentry"],"aioseo_notices":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/kabs.com\/en\/wp-json\/wp\/v2\/pages\/4710","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kabs.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/kabs.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/kabs.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kabs.com\/en\/wp-json\/wp\/v2\/comments?post=4710"}],"version-history":[{"count":0,"href":"https:\/\/kabs.com\/en\/wp-json\/wp\/v2\/pages\/4710\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kabs.com\/en\/wp-json\/wp\/v2\/media\/8712"}],"wp:attachment":[{"href":"https:\/\/kabs.com\/en\/wp-json\/wp\/v2\/media?parent=4710"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}